Here are relevant reports on : ai-in-scientific-research-market
-
Cloud AI Market by Cloud AI Infrastructure (Compute, Storage, Network), AI & ML Platforms (Auto ML), MLOps and Lifecycle Management (AI Workflow Orchestration), AIaaS, Technology (Generative AI and Other AI) - Global Forecast to 2029
The global cloud AI market is projected to reach USD 327.15 billion by 2029 at a CAGR of 32.4 % during the forecast period. Some of the significant cloud AI vendors include Google (US), IBM (US), AWS (US), Microsoft (US), Oracle (US), NVIDIA (US), Salesforce (US), SAP (Germany), Alibaba Cloud (China), HPE (US), and Intel (US).
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
InGaAs Camera Market by Camera Cooling technology (Cooled camera, Uncooled Camera), Scanning Type (Area Scan Camera, Line Scan Camera), Application (Military & Defense, Industrial Automation, Scientific Research), and Geography - Global Forecast to (2025-2035)
Some of the major players in this market are Hamamatsu (Japan), First Sensor (Germany), Jenoptik (Germany), Teledyne Technologies (US), Luna (US), Lumentum (US), Laser Components (Germany), Albis Optoelectronics (Switzerland), Thorlabs (US), Sensors Unlimited (US), FLIR Systems (US), Xenics (Belgium), New Imaging Technologies (France), Allied Vision Technologies (Germany), Raptor Photonics (UK), Sofradir (France), Princeton Instruments (US), Photon (Canada), Fermionics Opto-Technology (US), AC Photonics (US), GPD Optoelectronics (US), New England Photoconductor (US), QPHOTONICS (US), Episensors (US), and IRCameras (US).
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
RNAI Technology Market- by Application (Research, Therapeutics) - Global Forecasts to 2019
The report presents the latest advances in RNAi technologies and their clinical implication as a therapeutic platform. It charts the current trends in RNAi therapeutics, and analyzes the opportunities and challenges faced by the RNAi companies. The focus will be on the clinical needs, patented technologies and the competitive landscape across geographies.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016)
Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
LITHIUM Cobalt Oxide Market Research Report by Application, Type & Region
The growth of the Lithium cobalt oxide market is attributed to the increasing demand for lithium-ion batteries, which are used in a variety of applications, such as electric vehicles, consumer electronics, and energy storage. Lithium cobalt oxide is a key component of lithium-ion batteries, as it provides high energy density and long cycle life. The increasing demand for electric vehicles is a major driver for the growth of the lithium cobalt oxide market. The growth of the electric vehicle market is being driven by government regulations, rising environmental concerns, and declining battery prices.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Direct Conjugated Antibody Market by Application, Research Area, End User and Region - Global Forecast 2030
Direct conjugated antibodies are widely utilized in research and diagnosis, encompassing disciplines like immunology, cancer, and neuroscience. Direct conjugated antibodies are more in demand as a result of the increased prevalence of chronic diseases, rising R&D expenditures, and the requirement for precise diagnostics.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
AI Advertising Platform Market by Technology, Deployment, Industry, Region - Global Forecast to 2030
The market for AI advertising platforms has shown rapid expansion in recent years, and this trend is anticipated to continue. By introducing cutting-edge capabilities for data analysis, targeting, personalisation, and optimisation, AI technology has completely transformed the advertising sector.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Generative AI Outlook 2025 – Shaping the Future of Creative Intelligence
Global IT spending on devices, data center systems, enterprise software, IT services, and communications services is forecast to reach USD 5.7 trillion by 2025 (9.3% growth over 2024). OpenAI, Microsoft, Google, AWS, and Adobe are the major players in generative AI, with more than 45% combined market share in 2024. Other prominent market players are NVIDIA, Meta, Anthropic, Accenture, and IBM. In 2024, key generative AI providers strive to maintain their leadership positions with new product launches & product enhancements, multimodal AI advancements, strategic deals, and partnerships & collaborations. In 2025, Generative AI providers will invest in ethical AI frameworks, real-time multimodal capabilities, and AI democratization to enhance usability, address bias, and ensure data security, meeting the growing demand for personalized, transparent, and scalable AI solutions across industries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
AI in Life Science Market - Global Forecast 2030
The global AI in life sciences market, valued at US$2.31B in 2023, is forecasted to grow at a 27.3% CAGR, reaching US$2.93B by 2024 and US$11.78B by 2030. Growth is driven by AI’s role in accelerating drug discovery, significantly reducing the time and cost of identifying and developing new therapies. The growing demand for personalized medicine drives the adoption since AI analyses complex datasets in order to provide customized treatment options.
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
